These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 31421264)

  • 1. Natural product-based nanoformulations for cancer therapy: Opportunities and challenges.
    Kashyap D; Tuli HS; Yerer MB; Sharma A; Sak K; Srivastava S; Pandey A; Garg VK; Sethi G; Bishayee A
    Semin Cancer Biol; 2021 Feb; 69():5-23. PubMed ID: 31421264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology Approaches to Improving Cancer Immunotherapy.
    Hagan CT; Medik YB; Wang AZ
    Adv Cancer Res; 2018; 139():35-56. PubMed ID: 29941106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyphenol nanoformulations for cancer therapy: experimental evidence and clinical perspective.
    Davatgaran-Taghipour Y; Masoomzadeh S; Farzaei MH; Bahramsoltani R; Karimi-Soureh Z; Rahimi R; Abdollahi M
    Int J Nanomedicine; 2017; 12():2689-2702. PubMed ID: 28435252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology, in silico and endocrine-based strategy for delivering paclitaxel and miRNA: Prospects for the therapeutic management of breast cancer.
    Ansari MA; Thiruvengadam M; Farooqui Z; Rajakumar G; Sajid Jamal QM; Alzohairy MA; Almatroudi A; Alomary MN; Chung IM; Al-Suhaimi EA
    Semin Cancer Biol; 2021 Feb; 69():109-128. PubMed ID: 31891780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotherapeutics to overcome conventional cancer chemotherapy limitations.
    Chidambaram M; Manavalan R; Kathiresan K
    J Pharm Pharm Sci; 2011; 14(1):67-77. PubMed ID: 21501554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticles in precision medicine for ovarian cancer: From chemotherapy to immunotherapy.
    Li Y; Gao Y; Zhang X; Guo H; Gao H
    Int J Pharm; 2020 Dec; 591():119986. PubMed ID: 33069895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on Nanotechnology-based Drug Delivery Systems in Cancer Treatment.
    Ho BN; Pfeffer CM; Singh ATK
    Anticancer Res; 2017 Nov; 37(11):5975-5981. PubMed ID: 29061776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol nanoformulations: challenges and opportunities.
    Summerlin N; Soo E; Thakur S; Qu Z; Jambhrunkar S; Popat A
    Int J Pharm; 2015 Feb; 479(2):282-90. PubMed ID: 25572692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Applications of Curcumin Nanoformulations.
    Yallapu MM; Nagesh PK; Jaggi M; Chauhan SC
    AAPS J; 2015 Nov; 17(6):1341-56. PubMed ID: 26335307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Recent Advancement in Nanotechnology Approaches for the Treatment of Cervical Cancer.
    Hegde YM; Theivendren P; Srinivas G; Palanivel M; Shanmugam N; Kunjiappan S; Vellaichamy S; Gopal M; Dharmalingam SR
    Anticancer Agents Med Chem; 2023; 23(1):37-59. PubMed ID: 35570521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoformulation of natural products for prevention and therapy of prostate cancer.
    Sanna V; Siddiqui IA; Sechi M; Mukhtar H
    Cancer Lett; 2013 Jun; 334(1):142-51. PubMed ID: 23201598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology-based approaches in anticancer research.
    Jabir NR; Tabrez S; Ashraf GM; Shakil S; Damanhouri GA; Kamal MA
    Int J Nanomedicine; 2012; 7():4391-408. PubMed ID: 22927757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual delivery of biological therapeutics for multimodal and synergistic cancer therapies.
    Jang B; Kwon H; Katila P; Lee SJ; Lee H
    Adv Drug Deliv Rev; 2016 Mar; 98():113-33. PubMed ID: 26654747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smart Nanotherapeutic Targeting of Tumor Vasculature.
    Li Z; Di C; Li S; Yang X; Nie G
    Acc Chem Res; 2019 Sep; 52(9):2703-2712. PubMed ID: 31433171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy.
    Parhi P; Mohanty C; Sahoo SK
    Drug Discov Today; 2012 Sep; 17(17-18):1044-52. PubMed ID: 22652342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered nanoparticles for imaging and drug delivery in colorectal cancer.
    Pavitra E; Dariya B; Srivani G; Kang SM; Alam A; Sudhir PR; Kamal MA; Raju GSR; Han YK; Lakkakula BVKS; Nagaraju GP; Huh YS
    Semin Cancer Biol; 2021 Feb; 69():293-306. PubMed ID: 31260733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial of Special Issue "Surface-Functionalized Nanoparticles as Drug Carriers".
    Layek B; Singh J
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31861113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin nanomedicine: a road to cancer therapeutics.
    Yallapu MM; Jaggi M; Chauhan SC
    Curr Pharm Des; 2013; 19(11):1994-2010. PubMed ID: 23116309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoformulations of natural products for management of metabolic syndrome.
    Taghipour YD; Hajialyani M; Naseri R; Hesari M; Mohammadi P; Stefanucci A; Mollica A; Farzaei MH; Abdollahi M
    Int J Nanomedicine; 2019; 14():5303-5321. PubMed ID: 31406461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.